12:00 AM
 | 
Dec 18, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

AeroDose insulin: Began Phase II testing

AeroGen Inc. (AEGN), Sunnyvale, Calif.
Product: AeroDose insulin
Business: Metabolic
Therapeutic category: Metabolism
Target: Insulin receptors
Description: Inhaled insulin using AEGN's...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >